The Ins and Outs of the Minimally Invasive Whipple

Surgery
Summer 2016

“We are now routinely removing tumors safely with smaller incisions using the laparoscopic and robotic approaches.” - Matthew Weiss

Dr He & Dr Weiss

When deciding on a surgical approach, Jin He, left, and Matthew Weiss consider the type of tumor, prior surgical history, position of anatomy and major vessel involvement.

Surgeons at The Johns Hopkins Hospital have performed more than 5,000 Whipples since 1980. Today, the mortality rate is less than 1 percent—thanks to the efforts of pancreatic surgeon John Cameron, who drastically refined the procedure. Now, in select patients, surgeons at The Johns Hopkins Hospital are applying a minimally invasive approach to this operation.

“We are now routinely removing tumors safely with smaller incisions using the laparoscopic and robotic approaches,” says surgical oncologist Matthew Weiss.

In 2010, surgeon Marty Makary pioneered the laparoscopic Whipple at The Johns Hopkins Hospital. Surgical oncologist Jin He, a fellow at the time, attended Makary’s operations and is now using his experience to perform open and minimally invasive Whipples.

The principle for the minimally invasive Whipple is identical to an open Whipple but requires particular expertise. “It demands the skills of an expert pancreas surgeon and an expert minimally invasive surgeon,” says Weiss. “You have to know how to do the traditional open operation and minimally invasive procedures.”

Since 2014, Weiss, He and Christopher Wolfgang, director of hepatobiliary and pancreatic surgery, have performed more than 30 Whipples using a robotic approach. Preliminary data show zero infections at the surgery site and oncologic outcomes equivalent to those for open Whipples.

fast facts

“People may think you leave some tumor behind or you get less lymph nodes with a minimally invasive approach, but our data show equivalent oncological outcomes when the patient is a good candidate,” says He.

Approximately 50 percent of those who have open Whipples at The Johns Hopkins Hospital could be potential candidates for a minimally invasive approach. The robotic approach is appropriate for many cysts and tumors of the pancreas, including intraductal papillary mucinous neoplasms, neuroendocrine tumors and pancreas cancer.

However, Weiss says, each patient is different and has individual needs. Some of the factors the surgical oncologists consider when deciding on a surgical approach include type of tumor, prior surgical history, position of anatomy and major vessel involvement.

Even though the procedure takes longer than an open approach—six or seven hours, compared to three or four—the incision is much smaller. Afterward, patients stay in the hospital for about a week, and the smaller surgical site provides less opportunity for infection and less need for narcotics.

“We’re a high-volume pancreas surgery center with great outcomes,” says Weiss. “Now we are combining our extensive experiences in both pancreas surgery and minimally invasive approaches.”

To refer a patient: 410-933-7262

WATCH THIS

Matthew Weiss discusses minimally invasive options for pancreatic surgery.

Jin He discusses minimally invasive options for liver cancer and liver tumors.


© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Powered by the BroadcastMed Network